Charles Democko

Charles Democko joined Dren Bio as our SVP of Regulatory Affairs and Quality in September 2021. Mr. Democko most recently served as SVP of Regulatory Affairs and Quality for Catalyst Biosciences. During his time at Catalyst, he helped to build and lead their Regulatory and Quality functions to support the Phase 3 development of their lead asset. Prior to joining Catalyst, Mr. Democko previously served executive level regulatory and quality roles at CytomX Therapeutics, Ascendis Pharma, Kalobios, Novacea, and Connetics, as well as increasing levels of non-executive positions at Theravance, Elan, and Genentech. Mr. Democko began his career at the Battelle Memorial Institute (not for profit research institute) after obtaining his Bachelor of Science degree from the Ohio State University.